U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023 at 09:14 AM EST
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
